benefits and risks of ghk-cu peptide (Copper Peptide) Deep Dive: Mechanisms, Benefits, Risks, Forms, & Dosing The Ordinary Multi-Peptide + Copper

No direct trial evidence No published clinical trial has evaluated the four-peptide KLOW combination together, and the doses cited above are extrapolated from individual-component research and community protocols, not validated as a synergistic dose for the blend

Statistical analysis was performed using unpaired 2-tailed Students t test

Certain investigations have noted patterns of initial arousal followed by sedation, suggesting complex interactions with sleep architecture

J Alzheimers Dis 82(1):149157 Yu X, Zhang S, Zhao D, Zhang X, Xia C, Wang T, Zhang M, Liu T, Huang W, Wu B (2019) SIRT1 inhibits apoptosis in in vivo and in vitro models of spinal cord injury via microRNA-494